About: Jørgen Vestbo

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Jørgen Vestbo Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) researcher (en) 연구원 (ko) গবেষক (bn) 研究者 (ja) ഗവേഷകൻ (ml) araştırmacı (tr) wetenschapper (nl) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) hulumtues (sq)
rdfs:label	Jørgen Vestbo (en) Jørgen Vestbo (es) Jørgen Vestbo (nl) Jørgen Vestbo (sl) Jørgen Vestbo (ast)
skos:prefLabel	Jørgen Vestbo (en) Jørgen Vestbo (es) Jørgen Vestbo (nl) Jørgen Vestbo (sl) Jørgen Vestbo (ast)
name	Jørgen Vestbo (en) Jørgen Vestbo (es) Jørgen Vestbo (nl) Jørgen Vestbo (sl) Jørgen Vestbo (ast)
Scopus author ID	wds:Q41838693-F0159166-1B93-466C-BCE6-D7C41B264465
Scopus author ID	34573970200
given name	wds:Q41838693-C5796E3F-A727-4063-A91A-6BD44703182C
given name	Jørgen
instance of	wds:Q41838693-7FC965F5-634C-475D-9B9E-030484E96A01
instance of	Homo sapiens
award received	wds:Q41838693-02578f04-4a14-21f9-daff-b49ae4d4983c
award received	Hagedorn Prize
occupation	wds:Q41838693-273B502F-9C2B-46FF-9017-0972E8CEB7B7
employer	wds:Q41838693-E1B9995F-385E-4E46-876A-65438A3C1F9F wds:Q41838693-E9A71307-2139-49A5-8346-E698634C8047
sex or gender	wds:Q41838693-6A2FE9AD-A336-4E1F-97B1-5264015D5510
family name	wds:Q41838693-F2EBF97F-0AD3-40B5-BEBE-0559AFDF0F01
official website	wds:Q41838693-DEC194C0-9EC7-467F-A12D-9CEF71B8BFD2
occupation	researcher
employer	University of Manchester University of Southern Denmark
sex or gender	male
family name	Vestbø
official website	https://pureprojects.ppad.man.ac.uk/portal/en/researchers/jorgen-vestbo(c2488781-763f-441f-b0c6-8e74d58895e3).html
ORCID iD	wds:Q41838693-A22FC076-62FB-4ED8-A9F1-E4EA5134DAF1
ORCID iD	https://orcid.org/0000-0001-6355-6362
ORCID iD	0000-0001-6355-6362
Gateway to Research person ID	wds:Q41838693-A1C54AE7-2689-4F99-ACB4-D52BA727C90B
Gateway to Research person ID	313B7302-C43A-403D-8B55-045248152750
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q41838693
is author of	Onset of effect of aclidinium, a novel, long-acting muscarinic antagonist, in patients with COPD. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population Socioeconomic status and prognosis of COPD in Denmark Aortic augmentation index: reference values in a large unselected population by means of the SphygmoCor device. Use of different exhaled nitric oxide multiple flow rate models in COPD. Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease Health status in the TORCH study of COPD: treatment efficacy and other determinants of change Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study Cardiovascular events in patients with COPD: TORCH study results Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Adherence to inhaled therapy, mortality and hospital admission in COPD. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial The TORCH (towards a revolution in COPD health) survival study protocol Gender does not influence the response to the combination of salmeterol and fluticasone propionate in COPD. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study Sex Differences in Mortality and Clinical Expressions of Patients with Chronic Obstructive Pulmonary Disease Epidemiology of chronic obstructive pulmonary disease Integrated care pathways for airway diseases (AIRWAYS-ICPs). Sex differences in emphysema and airway disease in smokers. Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. Biomarkers in chronic obstructive pulmonary disease Statistical analysis of exacerbation rates in COPD: TRISTAN and ISOLDE revisited Improved survival prediction from lung function data in a large population sample Changes in forced expiratory volume in 1 second over time in COPD. Potential misclassification of causes of death from COPD. A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma Opportunities and challenges in the genetics of COPD 2010: an International COPD Genetics Conference report A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype The COPD Biomarker Qualification Consortium (CBQC). Lessons from ECLIPSE: a review of COPD biomarkers Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Vitamin D, vitamin D binding protein, lung function and structure in COPD. Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals. Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software